Price $26.25 |
Market Cap
838.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.31
|
P/S
1.64
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
33.3
|
Op. Cash Flow
33.2K
|
FCF
0.7
|
|
Op. Margin
-11.50%
|
Net Margin
-9.60%
|
ROE
-12.60%
|
ROI
-1.30%
|
|
ROA
-7.70%
|
EPS Growth
-103.80%
|
Current Ratio
2.1
|
Debt/Equity
17.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc (ZBH) | $123.45 | - | 0.80% | 23.46B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $1.95 | - | - | 72.7M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $6.18 | - | - | 106.5M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $43.10 | - | - | 1.31B | Strong Buy |
| Dynatronics Corporation (DYNT) | $1.53 | - | - | 14.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
